Does BUROSUMAB Cause Product dose omission issue? 124 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 124 reports of Product dose omission issue have been filed in association with BUROSUMAB (CRYSVITA). This represents 18.4% of all adverse event reports for BUROSUMAB.
124
Reports of Product dose omission issue with BUROSUMAB
18.4%
of all BUROSUMAB reports
0
Deaths
12
Hospitalizations
How Dangerous Is Product dose omission issue From BUROSUMAB?
Of the 124 reports, 12 (9.7%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BUROSUMAB. However, 124 reports have been filed with the FAERS database.
What Other Side Effects Does BUROSUMAB Cause?
Pain (69)
Inappropriate schedule of product administration (64)
Arthralgia (59)
Therapy interrupted (57)
Blood phosphorus decreased (53)
Pain in extremity (50)
Restless legs syndrome (49)
Back pain (35)
Fatigue (34)
Headache (31)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which BUROSUMAB Alternatives Have Lower Product dose omission issue Risk?
BUROSUMAB vs BUROSUMAB-TWZA
BUROSUMAB vs BUSPIRONE
BUROSUMAB vs BUSULFAN
BUROSUMAB vs BUSULFEX
BUROSUMAB vs BUTALBITAL